Kearns & Associates LLC Royalty Pharma PLC Transaction History
Kearns & Associates LLC
- $155 Million
- Q4 2024
A detailed history of Kearns & Associates LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Kearns & Associates LLC holds 17,685 shares of RPRX stock, worth $531,964. This represents 0.29% of its overall portfolio holdings.
Number of Shares
17,685Holding current value
$531,964% of portfolio
0.29%Shares
1 transactions
Others Institutions Holding RPRX
# of Institutions
410Shares Held
283MCall Options Held
578KPut Options Held
47.5K-
Morgan Stanley New York, NY41.1MShares$1.24 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.6MShares$1.13 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$692 Million0.01% of portfolio
-
Baillie Gifford & CO16.1MShares$485 Million0.35% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$366 Million0.39% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $13.1B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...